The British government has indefinitely banned puberty blockers for children with gender dysphoria after independent experts found there was an unacceptable safety risk in prescribing the medication.

Frequently asked questions about gender transition care for minors, including what puberty blockers are and whether cross-sex hormones impact fertility.

A freeze placed this year on their use to treat gender dysphoria will remain in place for young people under 18, except in clinical trials, Britain’s government said.

The United Kingdom announced an indefinite ban on the use of puberty blockers for those under the age of 18 years with gender dysphoria, except in clinical trials. The decision formalizes temporary restrictions imposed earlier this year.

The United Kingdom has moved to ban the use of puberty blockers on trans-identified children for the foreseeable future, save for clinical trials

The United Kingdom on Wednesday indefinitely banned puberty-blocking drugs as a treatment for minors with gender dysphoria, except in clinical trials, due to an “unacceptable safety risk.” “Existing emergency measures banning the sale and supply of puberty-suppressing hormones will be made indefinite,

The UK government will indefinitely ban prescriptions of puberty blockers for children in cases of gender dysphoria, the condition characterized by distress over the incongruence between one’s gender identity and birth-assigned sex.

The ban appears to apply only to trans kids using blockers to treat gender dysphoria; cisgender kids experiencing precocious puberty will still be able to access the treatment.

Puberty blockers for under-18s with gender dysphoria will be banned indefinitely in the UK, outside clinical trials, the Department of Health and Social Care has announced.

It is just the latest nation in Europe to restrict health care access for transgender youth, citing safety risks.